RMRoger E. Marchant

Roger E. Marchant

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Roger E. Marchant has a total of 27 co-authors. Here are the top co-authors by number of shared publications:

  • Kandice Kottke-Marchant

    Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio

    6 shared publications
  • Aryavarta M. S. Kumar

    Louis Stokes Cleveland VA Medical Center

    3 shared publications
  • Chad Tang

    Department of Biomedical Engineering, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, Ohio 44106, and Department of Clinical Pathology, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195

    3 shared publications
  • Coby C. Larsen

    Department of Biomedical Engineering, Case Western Reserve University, 10900 Euclid Avenue, Wickenden 309, Cleveland, Ohio 44106

    3 shared publications
  • Faina Kligman

    Department of Biomedical Engineering, Case Western Reserve University, 10900 Euclid Avenue, Wickenden 309, Cleveland, Ohio 44106

    3 shared publications
  • Jeffrey A. Beamish

    Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio 44106-7207, USA

    3 shared publications

Latest Publications

  • Targeted delivery of vancomycin to Staphylococcus epidermidis biofilms using a fibrinogen‐derived peptide

    by Christopher M. Hofmann, James M. Anderson, Roger E. Marchant

    This study reports on the use of a fibrinogen‐derived peptide for the specific targeting and delivery of vancomycin to Staphylococcus epidermidis biofilms. One method by which S. epidermidis initially adheres to biomaterials uses the plasma protein fibrinogen as an intermediary, where the S. epidermidis surface protein SdrG binds to a short amino acid sequence near the amino terminus of the Bβ chain of fibrinogen. We mimicked this binding interaction and demonstrated the use of a synthetic fibrinogen‐based β6‐20 peptide to target and deliver vancomycin to S. epidermidis in vitro. The β6‐20 peptide was synthesized and labeled with a Nanogold probe, and its targeting capabilities were examined through the use of scanning electron microscopy. The Nanogold component was then replaced by vancomycin, utilizing a flexible, variable length poly(ethylene glycol) linker between the peptide and antibiotic to create the targeted vancomycin products, β6‐20‐PEGx‐VAN. Initial binding to surface adherent S. epidermidis was increased in a concentration‐dependent manner relative to vancomycin for all equivalent concentrations ≥4 μg/mL, with targeted vancomycin content up to 22.9 times that of vancomycin alone. Retention of the targeted antibiotics was measured after an additional 24‐h incubation period, revealing levels 1.3 times that of vancomycin. The results demonstrate the improved targeting and retention of vancomycin within a biofilm due to the incorporation of a specific targeting motif. © 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 100A: 2517–2525, 2012.


  • Disruption of Staphylococcus epidermidis biofilm formation using a targeted cationic peptide

    by Christopher M. Hofmann, Kyle J. Bednar, James M. Anderson, Roger E. Marchant

    This study reports the use of a targeted cationic peptide with the ability to disrupt Staphylococcus epidermidis biofilm formation. Complications due to nosocomial infections of implanted medical devices pose a significant health risk to patients, with Staphylococcus epidermidis often implicated in the case of blood-contacting biomaterials. S. epidermidis virulence relies mainly on its ability to form a biofilm, the main component of which is polysaccharide intercellular adhesin (PIA). We utilized the synthetic β6-20 peptide, known to specifically bind S. epidermidis, in order to deliver a cationic polylysine peptide (G3K6) to the bacterial surface and disrupt the charge–charge interactions needed for PIA retention and biofilm stability. The effects of the β6-20-G3K6 peptide on biofilm formation were assessed using optical density, fluorescently labeled wheat germ agglutinin, nucleic acid stain (SYTO 9), and a metabolic assay (XTT, 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide inner salt). Biofilms formed in the presence of β6-20-G3K6 peptide (100 μM) resulted in a 37.9% reduction in PIA content and a 17.5% reduction of adherent bacteria relative to biofilms grown in the absence of peptide. These studies demonstrate the targeting ability of the β6-20 peptide towards biomaterial-adherent S. epidermidis, and highlight the potential for disrupting the early stages of biofilm formation. © 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A:, 2012.


  • Biomimetic Poly(ethylene glycol)-Based Hydrogels as Scaffolds for Inducing Endothelial Adhesion and Capillary-Like Network Formation

    by Junmin Zhu, Ping He, Lin Lin, Derek R. Jones, Roger E. Marchant

    The extracellular matrix (ECM) is an attractive model for designing synthetic scaffolds with a desirable environment for tissue engineering. Here, we report on the synthesis of ECM-mimetic poly(ethylene glycol) (PEG) hydrogels for inducing endothelial cell (EC) adhesion and capillary-like network formation. A collagen type I-derived peptide GPQGIAGQ (GIA)-containing PEGDA (GIA-PEGDA) was synthesized with the collagenase-sensitive GIA sequence attached in the middle of the PEGDA chain, which was then copolymerized with RGD capped-PEG monoacrylate (RGD-PEGMA) to form biomimetic hydrogels. The hydrogels degraded in vitro with the rate dependent on the concentration of collagenase and also supported the adhesion of human umbilical vein ECs (HUVECs). Biomimetic RGD/GIA-PEGDA hydrogels with incorporation of 1% RGD-PEGDA into GIA-PEGDA hydrogels induced capillary-like organization when HUVECs were seeded on the hydrogel surface, while RGD/PEGDA and GIA-PEGDA hydrogels did not. These results indicate that both cell adhesion and biodegradability of scaffolds play important roles in the formation of capillary-like networks.


  • Molecular Regulation of Contractile Smooth Muscle Cell Phenotype: Implications for Vascular Tissue Engineering

    by Jeffrey A. Beamish, Ping He, Kandice Kottke-Marchant, Roger E. Marchant

    The molecular regulation of smooth muscle cell (SMC) behavior is reviewed, with particular emphasis on stimuli that promote the contractile phenotype. SMCs can shift reversibly along a continuum from a quiescent, contractile phenotype to a synthetic phenotype, which is characterized by proliferation and extracellular matrix (ECM) synthesis. This phenotypic plasticity can be harnessed for tissue engineering. Cultured synthetic SMCs have been used to engineer smooth muscle tissues with organized ECM and cell populations. However, returning SMCs to a contractile phenotype remains a key challenge. This review will integrate recent work on how soluble signaling factors, ECM, mechanical stimulation, and other cells contribute to the regulation of contractile SMC phenotype. The signal transduction pathways and mechanisms of gene expression induced by these stimuli are beginning to be elucidated and provide useful information for the quantitative analysis of SMC phenotype in engineered tissues. Progress in the development of tissue-engineered scaffold systems that implement biochemical, mechanical, or novel polymer fabrication approaches to promote contractile phenotype will also be reviewed. The application of an improved molecular understanding of SMC biology will facilitate the design of more potent cell-instructive scaffold systems to regulate SMC behavior.


  • The effects of heparin releasing hydrogels on vascular smooth muscle cell phenotype

    by Jeffrey A. Beamish, Leah C. Geyer, Nada A. Haq-Siddiqi, Kandice Kottke-Marchant, Roger E. Marchant


  • The influence of RGD-bearing hydrogels on the re-expression of contractile vascular smooth muscle cell phenotype

    by Jeffrey A. Beamish, Alexander Y. Fu, Ae-Jin Choi, Nada A. Haq, Kandice Kottke-Marchant, Roger E. Marchant


  • The effects of monoacrylated poly(ethylene glycol) on the properties of poly(ethylene glycol) diacrylate hydrogels used for tissue engineering

    by Jeffrey A. Beamish, Junmin Zhu, Kandice Kottke‐Marchant, Roger E. Marchant

    This study investigated the effects of poly(ethylene glycol) monoacrylate (PEGMA) on the properties of poly(ethylene glycol) diacrylate (PEGDA)‐co‐PEGMA hydrogel networks. The PEGMA materials utilized were similar to ligand‐linked materials typically copolymerized with PEGDA for use as tissue engineering scaffolds. PEGDA (5–20% wt/wt, 6 kDa) and PEGMA (0–20% wt/wt, 0–43 mM, 5 kDa) were copolymerized by photo‐initiated free radical polymerization and the mass swelling ratio and shear modulus of the resulting hydrogels were determined. Increasing the prepolymerization concentration of PEGMA decreased the swelling ratio by up to 42 ± 1.6% and increased the shear modulus by up to 167 ± 29.3%, suggesting that PEGMA enhanced gel cross‐linking. Analysis of the effective number of cross‐linked chains per PEGDA, calculated independently from swelling and mechanical data, indicated each PEGDA participated in more cross‐links as PEGMA was added. The results suggest that PEGMA‐co‐PEGDA gels can be formed with higher concentrations of PEGMA‐tethered ligands than previously reported allowing the formation of scaffolds with a rich diversity of biological functionalities without sacrificing the integrity of the gel network. © 2009 Wiley Periodicals, Inc. J Biomed Mater Res, 2010


  • Design and Synthesis of Biomimetic Hydrogel Scaffolds with Controlled Organization of Cyclic RGD Peptides

    by Junmin Zhu, Chad Tang, Kandice Kottke-Marchant, Roger E. Marchant

    We report on the rational design and synthesis of a new type of bioactive poly(ethylene glycol) diacrylate (PEGDA) macromers, cyclic Arg-Gly-Asp (cRGD)-PEGDA, to mimic the cell-adhesive properties of extracellular matrix (ECM), aiming to create biomimetic scaffolds with controlled spatial organization of ligands and enhanced cell binding affinity for tissue engineering. To attach the cRGD peptide in the middle of PEGDA chain, a tailed cRGD peptide, c[RGDfE(SSSKK-NH2)] (1), was synthesized with c(RGDfE) linked to a tail of SSSKK. The tail consists of a spacer with three serine residues and a linker with two lysine residues for conjugating with acryloyl-PEG-NHS (5) to create cRGD-PEGDA (6). cRGD-PEGDA possesses good photopolymerization ability to fabricate hydrogel scaffolds under UV radiation. Surface morphology and composition analysis demonstrates that cRGD-PEGDA hydrogels were well-constructed with porous three-dimensional (3D) structures and uniform distribution of cRGD ligands. Our results show that cRGD-PEGDA hydrogels facilitate endothelial cell (EC) adhesion and spreading on the hydrogel surfaces and exhibit significantly higher EC population in comparison with linear RGD-modified hydrogels at low peptide incorporation. Since ligand presentation in biomimetic scaffolds plays an important role in controlling cell behavior, cRGD-PEGDA has great advantages of controlling hydrogel properties and ligand spatial organization in the resulting scaffolds. Furthermore, cRGD-PEGDA is an attractive candidate for the future development of tissue engineering scaffolds with optimum cell adhesive strength and ligand density.


  • Effect of Monomer Structure and Solvent on the Growth of Supramolecular Nanoassemblies on a Graphite Surface

    by Aryavarta M. S. Kumar, Justin D. Fox, Lauren E. Buerkle, Roger E. Marchant, Stuart J. Rowan

    The self-assembly of high aspect ratio hierarchical surface assemblies, as observed by fluid tapping mode AFM, can be achieved through careful design of the supramolecular interactions between low-molecular-weight adsorbates. Needlelike assemblies of monotopic guanine end-capped alkanes grow on a graphite surface when deposited from a water/DMSO solution. The growth of these assemblies can be monitored by AFM in real time, and the growth rate along the two different axes can be understood (through molecular modeling) in terms of the specific adsorbate−adsorbate interactions along those axes. Additionally, through judicious solvent selection (e.g., use of non-H-bonding solvents such as o-dichlorobenzene), which allows the formation of hydrogen-bonding aggregates in solution and influences the surface−adsorbate interactions, dramatically different surface assemblies of these guanine derivatives are obtained.


  • Platelet and endothelial adhesion on fluorosurfactant polymers designed for vascular graft modification

    by Chad Tang, Faina Kligman, Coby C. Larsen, Kandice Kottke‐Marchant, Roger E. Marchant

    A prominent failure mechanism of small diameter expanded polytetrafluoroethylene (ePTFE) vascular grafts is platelet‐mediated thrombosis. We have designed a surface modification for ePTFE consisting of a self‐assembling fluorosurfactant polymer (FSP) bearing biologically active ligands, including adhesive peptides and polysaccharide moieties. The goal of this biomimetic construct is to improve graft hemocompatibility by promoting rapid surface endothelialization, whereas minimizing platelet adhesion. Here we present a direct comparison of platelet and endothelial cell (EC) adhesion to FSPs containing one of three cell‐adhesion peptides: cyclic Arg‐Gly‐Asp‐D‐Phe‐Glu (cRGD), cyclic *Cys‐Arg‐Arg‐Glu‐Thr‐Ala‐Trp‐Ala‐Cys* (cRRE, *denotes disulfide bond cyclization), linear Gly‐Arg‐Gly‐Asp‐Ser‐Pro‐Ala (RGD), or a polysaccharide moiety: oligomaltose (M‐7), later designed to prevent nonspecific protein adhesion. Measurements of soluble peptide‐integrin binding indicated that cRRE exhibits very low affinity for the αIIbβ3 platelet fibrinogen receptor. Static and dynamic adhesion of washed, activated platelets on FSP‐modified surfaces revealed that M‐7 and cRRE promote significantly less platelet adhesion compared to RGD and cRGD FSPs, whereas EC adhesion was similar on all peptide FSPs and minimal on M‐7 FSP. These results illustrate the potential for ligands presented in a FSP surface modification to selectively adhere ECs with limited platelet attachment. © 2008 Wiley Periodicals, Inc. J Biomed Mater Res 2009